Ortega, Nolan Jun L.
HRN: 25-63-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/12/2024
08/19/2024
IV
300mg
Q8h
Multiple Facial Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes